Mr. Adamou has 15 years of experience in the healthcare industry with an established track record for concluding global transactions of multi-year partnerships with biotechnology and pharmaceutical companies located in North America, Europe and Japan. In his current function, Mr. Adamou is responsible for leading the Strategic Transaction Team located in the U.S. in structuring, negotiating and managing global strategic collaborations across a broad array of deal structures and across various therapeutic categories.

Mr. Adamou joined Boehringer Ingelheim in 2002, having previously held positions in business development at MedImmune, Inc., and research at Smithkline Beecham and Allelix Biopharmaceuticals. Mr. Adamou holds a B.S. and M.S. degrees in Molecular Biology and Genetics from the University of Guelph, Ontario, Canada.